Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 17 Source: CRO
- €4.1 billion turnover
-
€229.2 million
profit - 10,400 employees
-
30th Jun 16 Source: CRO
- €5 billion turnover
- 13,300 employees
- 3 more years available »
Ranking
By Turnover
(€4.1 billion)- 25th in Top Companies
- 6th in Health
- 5th in Pharma
By Employees
(10,400)- 20th in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.1 billion
Employees
- Uwe Röhrhoff CEO/Managing Director
Latest News
- 7:58am Ireland does not have a ‘functioning’ new homes sector - Cairn Homes
- 7:51am Apple boss Tim Cook says tech industry regulation ‘inevitable’
- 6:40am Revenue nabs almost 200, Irish start-up hopes for ‘glamping’ boost
- 6:30am Post-Brexit bonus for Ireland? Not from Japan
- 5:45am Irish start-up wins contract worth nearly €3m to supply pre-fab homes to Canada